Arterys, the developer of a medical imaging platform for blood flow, has completed a $12m round that included Stanford's StartX Fund.
US-based medical imaging technology developer Arterys closed a $12m series A round yesterday featuring Stanford University’s StartX Fund.
Life sciences investment firm Emergent Medical Partners led the round, which also included GE Ventures, industrial equipment and appliance conglomerate General Electric’s corporate venturing unit, Norwich Ventures, Asset Management Ventures, AME Cloud Ventures and Morado Ventures.
Arterys has built a cloud-based medical imaging platform that uses cloud computation and machine learning to visualise blood flow inside the heart in 3D, allowing it to be more closely analysed. The funding will be used to grow Arterys’ commercial operations.
Fabien Beckers, founder and CEO of Arterys, said: “This financing includes premier organisations in the healthcare field who recognise the game-changing value of our solution to revolutionise medical imaging and improve patient care.
“We plan to staff strategically as we expand our commercial presence both in the United States and Europe, while at the same time applying our medical imaging solutions beyond cardiac care in neurology and oncology.”
– A version of this article first appeared on our sister site Global Corporate Venturing.
